中国医药导刊
中國醫藥導刊
중국의약도간
CHINESE JOURNAL OF MEDICAL GUIDE
2013年
2期
314-315
,共2页
谢伟成%程淑琴%谢碧霞%林翠芳
謝偉成%程淑琴%謝碧霞%林翠芳
사위성%정숙금%사벽하%림취방
急性早幼粒细胞性白血病%维甲酸%化疗%砷剂
急性早幼粒細胞性白血病%維甲痠%化療%砷劑
급성조유립세포성백혈병%유갑산%화료%신제
Acute promyelocytic leukemia%Tretinoin%Chemotherapy%Arsenical
目的:观察维甲酸、三氧化二砷与化学治疗(化疗)联合治疗急性早幼粒细胞性白血病的疗效.方法:将68例初诊住院治疗的急性早幼粒细胞性白血病患者随机分为治疗组和对照组各34例.治疗组采用去甲氧柔红霉素+阿糖胞苷化疗加全反式维甲酸、三氧化二砷诱导治疗,即:采用诱导治疗方案,全反式维甲酸每日25mg/m2,分3次口服,连续给药4~6周;三氧化二砷10mg,静脉滴注,1次/日,连续治疗2~4周,至骨髓形态学完全缓解.待诱导分化开始3~5日后予去甲氧柔红霉素[商品名善维达,通用名盐酸伊达比星,用法:(8~12)mg/m2/天,化疗第1天,第3天,第5天+阿糖胞苷(75mg/m2,1次/12h)]方案化疗.对照组采用IA方案,即:去甲氧柔红霉素+阿糖胞苷,剂量用法同前.两组疗程为28日,疗程结束后进行血常规和骨髓象检测,如果未达到完全缓解(CR),则进行下一疗程继续用药直至完全缓解.结果:PR再次用药达到完全缓解所需时间比较,治疗组显著短于对照组(P<0.05);血常规恢复时间比较,治疗组优于对照组(P<0.05).结论:维甲酸三氧化二砷与化疗联合治疗急性早幼粒细胞性白血病短期疗效显著,达到完全缓解的时间缩短,血小板计数恢复快.
目的:觀察維甲痠、三氧化二砷與化學治療(化療)聯閤治療急性早幼粒細胞性白血病的療效.方法:將68例初診住院治療的急性早幼粒細胞性白血病患者隨機分為治療組和對照組各34例.治療組採用去甲氧柔紅黴素+阿糖胞苷化療加全反式維甲痠、三氧化二砷誘導治療,即:採用誘導治療方案,全反式維甲痠每日25mg/m2,分3次口服,連續給藥4~6週;三氧化二砷10mg,靜脈滴註,1次/日,連續治療2~4週,至骨髓形態學完全緩解.待誘導分化開始3~5日後予去甲氧柔紅黴素[商品名善維達,通用名鹽痠伊達比星,用法:(8~12)mg/m2/天,化療第1天,第3天,第5天+阿糖胞苷(75mg/m2,1次/12h)]方案化療.對照組採用IA方案,即:去甲氧柔紅黴素+阿糖胞苷,劑量用法同前.兩組療程為28日,療程結束後進行血常規和骨髓象檢測,如果未達到完全緩解(CR),則進行下一療程繼續用藥直至完全緩解.結果:PR再次用藥達到完全緩解所需時間比較,治療組顯著短于對照組(P<0.05);血常規恢複時間比較,治療組優于對照組(P<0.05).結論:維甲痠三氧化二砷與化療聯閤治療急性早幼粒細胞性白血病短期療效顯著,達到完全緩解的時間縮短,血小闆計數恢複快.
목적:관찰유갑산、삼양화이신여화학치료(화료)연합치료급성조유립세포성백혈병적료효.방법:장68례초진주원치료적급성조유립세포성백혈병환자수궤분위치료조화대조조각34례.치료조채용거갑양유홍매소+아당포감화료가전반식유갑산、삼양화이신유도치료,즉:채용유도치료방안,전반식유갑산매일25mg/m2,분3차구복,련속급약4~6주;삼양화이신10mg,정맥적주,1차/일,련속치료2~4주,지골수형태학완전완해.대유도분화개시3~5일후여거갑양유홍매소[상품명선유체,통용명염산이체비성,용법:(8~12)mg/m2/천,화료제1천,제3천,제5천+아당포감(75mg/m2,1차/12h)]방안화료.대조조채용IA방안,즉:거갑양유홍매소+아당포감,제량용법동전.량조료정위28일,료정결속후진행혈상규화골수상검측,여과미체도완전완해(CR),칙진행하일료정계속용약직지완전완해.결과:PR재차용약체도완전완해소수시간비교,치료조현저단우대조조(P<0.05);혈상규회복시간비교,치료조우우대조조(P<0.05).결론:유갑산삼양화이신여화료연합치료급성조유립세포성백혈병단기료효현저,체도완전완해적시간축단,혈소판계수회복쾌.
Objective:To investigate the clinical effects of tretinoin,arsenic trioxide on curing acute promyelocytic leukemia. Methods:Divide 68 patients who got the disease of acute promyelocytic leukemia,and received the tentative diagnosis and treatment in the hospital,into the treatment group and control group equally and randomly.The patients in both groups take with the same IA chemotherapy schedule.The patients in the treatment group take the induction therapy,namely,(25~45)mg/m2 of all- trans tretinoin per day,oral administration for three times, dosed for 4 to 6 weeks in a row.10 mg of arsenic trioxide, one time a day of intravenous drip,treated continuously for 2 to 4 weeks until the bone marrow morphology is remitted completely.The standard IA chemotherapy schedule will not be taken until the induced differentiation has proceeded for 3 to five days.The control group takes the single-purpose IA chemotherapy schedule,and the usage and dosage are the same as treatment group.28 days is a course of treatment in both groups.Result:if the purpose of complete remission (CR) is not achieved, continue using the medicine until complete remission.Results:The comparison of time for complete remission on PR( Partial remission) after medicine once again, the time of treatment group is lower than it in control group significantly(P<0.05).The comparison of recovery time on blood routine,the treatment group is superior to the control group (P<0.05). Conclusion:The short- term effects on acute promyelocytic leukemia with tretinoin,arsenic trioxide and chemotherapy is significant, the target of time contraction for complete remission is reached,and the recovery rate of platelet count is fast.